JBS S.A. Earnings Call Balances Growth With Strain

Jbs S.A. ((JBS)) has held its Q1 earnings call. Read on for the main highlights of the call.

JBS S.A.’s latest earnings call painted a balanced picture of strength and strain. Management highlighted record first-quarter net sales, resilient margins in several international units, and a fortified balance sheet, but also faced up to heavy cash burn, a sharp EBITDA drop, and deep U.S. beef losses that are likely to keep pressure on results into 2026.

Record Net Sales Signal Demand Resilience

JBS reported record first-quarter net sales of roughly $21–22 billion, up about 11% from a year earlier. The top-line growth underscored solid global demand across its protein portfolio, even as profitability and cash generation lagged the revenue momentum.

Profitability Holds Positive, Despite Margin Pressure

Adjusted EBITDA under IFRS reached about $1.1 billion, implying a 5.2% margin, while U.S. GAAP EBITDA came in at $960 million with a 4.2% margin. Net income was around $221–222 million, or $0.21 per share, and adjusted net income was $241 million, or $0.23 per share, supporting robust returns on equity and invested capital of 22% and 15% respectively.

Brazil, Seara and Australia Anchor Operating Strength

Key international segments delivered standout results that helped offset weakness elsewhere in the portfolio. Seara generated a 15.5% EBITDA margin on strong export demand and higher value-added products, while JBS Brazil posted a 4.5% margin and Australia delivered 7.1%, supported by favorable cattle conditions in Queensland.

Balance Sheet Fortified With Long-Dated Debt

The company moved aggressively to strengthen its liability profile by issuing $2.5 billion in bonds and completing a $1.45 billion tender offer. These actions extended average debt maturity to about 15.6 years at an average cost near 5.7%, kept net leverage at about 2.77x within the 2x–3x target, and preserved ample liquidity through $3.5 billion in cash and $3.4 billion in revolving credit lines.

Automation and AI Target Higher Productivity

JBS is deploying automation and artificial intelligence across its global footprint after over a year of pilot projects, aiming to sharpen both operational and commercial decisions. Seara and other units are investing in process upgrades and higher value-added categories, seeking to boost productivity and mix even as broader market margins tighten.

Pivoting Commercially Around Trade Disruptions

Management described a proactive commercial response to China safeguard changes and other trade frictions, which have complicated flows and pricing. The company is rebalancing volumes within quota regimes and tapping alternatives such as the United States, Mexico and Indonesia to protect value and broaden its export footprint.

SEC Filings to Open Index and Capital Access

In a strategic move for capital markets visibility, JBS will begin voluntarily filing 10-K, 10-Q and 8-K reports with the U.S. securities regulator under IFRS, supplemented with U.S. GAAP indicators. The goal is to qualify its shares for major U.S. index families, potentially unlocking incremental passive investment flows over time.

U.S. Beef Losses Remain a Major Drag

The North American beef unit was the clear weak spot, posting a negative EBITDA of roughly $230 million and a margin of about minus 2.3%. Management cited tight cattle supplies, higher costs, seasonal effects and ongoing plant footprint adjustments, and warned that while some improvement is expected, structural pressures mean 2026 is likely to be tougher than 2025.

Heavy Free Cash Flow Deficit Raises Concerns

First-quarter free cash flow was deeply negative at around $1.5 billion, materially worse than the roughly $970 million cash consumption a year earlier. The deficit reflected the combination of lower adjusted EBITDA, elevated capital spending and adverse working capital movements, and it stands out as a core investor concern.

Expansion CapEx Surges as Growth Bets Mount

Total capital expenditures jumped to about $566 million in the quarter, more than doubling versus the prior year. Expansion CapEx surged to roughly $390 million from $79 million, underscoring a major step-up in growth projects that are expected to enhance capacity and value-add, but that also weighed heavily on near-term cash flows.

EBITDA Step-Down Versus Last Year Hits Cash

Management highlighted an adjusted EBITDA decline of about $400 million year-over-year as a key driver of weaker cash generation. Even with record sales, the lower profitability base magnified the impact of higher CapEx and working capital on the company’s free cash flow profile.

Working Capital Distorted by Deferred Livestock Payments

Working capital dynamics were skewed by an additional $252 million of deferred payments to livestock suppliers, which management emphasized is largely a timing issue. Excluding this deferral, working capital performance would have been around 23% better than in the first quarter of the prior year, suggesting some of the drag may unwind over 2026.

FX and Trade Frictions Erode Margins

Sequential margin compression in strong segments like Seara and Australia was attributed partly to currency swings and trade disruptions. Seara faced roughly a 10% foreign-exchange headwind, while Australia saw about 300 basis points of margin contraction year-over-year, compounded by the added logistics complexity of rerouted trade lanes.

Leverage Near Upper Band Limits Flexibility

With net leverage at roughly 2.77x, JBS sits close to the 3.0x ceiling of its long-term target range, limiting room for aggressive shareholder payouts without earnings improvement. Management expects year-end leverage to land between about 2.5x and 3.0x, implying a continued focus on balance sheet discipline amid a murky operating environment.

Guidance: Second-Half Cash Rebound Amid Tough 2026

Management reiterated a CapEx framework of roughly $2.4 billion for the year, including about $1 billion earmarked for growth projects, and pointed to stronger cash generation in the second half as volumes and margins seasonally improve. Even so, they flagged that industry margins in 2026 could be 1.0–1.5 percentage points lower than 2025, making disciplined capital allocation and the breakeven EBITDA range of about $5.7–6.0 billion key markers for investors.

JBS’s call ultimately balanced confident long-term positioning against acute near-term pressures. Record sales, resilient international operations, and a well-structured balance sheet offer support, but deep U.S. beef losses, negative free cash flow and high CapEx keep risk levels elevated, leaving investors to weigh a potential second-half recovery against a tougher 2026 backdrop.